Related Experiment Videos

Chromosomal origin of acetyltransferase AAC(6') specifying amikacin resistance in Serratia marcescens

R Gómez-Lus1, M J Rivera, D Bobey

  • 1Department of Microbiology, School of Medicine, Zaragoza, Spain.

Microbiologia (Madrid, Spain)
|October 1, 1987
PubMed

Insights

Two Serratia marcescens strains exhibit antibiotic resistance. One strain

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Clinical isolates of Serratia marcescens can develop resistance to multiple antibiotics, including aminoglycosides.
  • Aminoglycoside resistance is often mediated by aminoglycoside-modifying enzymes.

Purpose of the Study:

  • To investigate the aminoglycoside-modifying enzymes present in two clinical isolates of Serratia marcescens exhibiting amikacin resistance.
  • To determine the genetic basis of aminoglycoside resistance in these strains.

Main Methods:

  • Phenotypic characterization of antibiotic resistance.
  • Enzyme assays to identify aminoglycoside-modifying enzymes.
  • Plasmid analysis and conjugation experiments.

Main Results:

  • Both Serratia marcescens strains possessed an acetyltransferase AAC(6") conferring amikacin resistance.
  • Strain 737 harbored a plasmid (pUZ 737) encoding a nucleotidyltransferase ANT(2") for gentamicin/tobramycin resistance and a phosphotransferase APH(3") for kanamycin/neomycin resistance.
  • Strain 1830, lacking extrachromosomal DNA, only produced AAC(6"), suggesting chromosomal gene encoding.

Conclusions:

  • Aminoglycoside resistance in Serratia marcescens can be mediated by both plasmid-borne and chromosomally encoded enzymes.
  • The AAC(6") enzyme, conferring amikacin resistance, appears to be chromosomally encoded in strain 1830, independent of plasmid presence.

Related Concept Videos